Ultrasmall silica nanoparticles directly ligate the T cell receptor complex

Authors:

Abstract
The impact of ultrasmall nanoparticles (4]. For both safety and therapeutic applications, a mechanism of action greatly facilitates translation. This work shows that ultrasmall amorphous silica nanoparticles directly ligate the T cell receptor (TCR) complex, notably the extracellular domains of CD3, and initiate signaling downstream. This surprising receptor selectivity, the well-known safety of the rapidly formed degradation product and the low cost of silica, bode well for use of these particles as affordable and accessible therapeutic TCR:CD3 agonists.
Funding Information
  • RCUK | Medical Research Council (MR/R005699/1)
  • Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (RGPIN-2014-06497)

This publication has 60 references indexed in Scilit: